section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
42/1998<br />
22 Oct/oct 1998 PCT Gazette - Section I - Gazette du PCT 14673<br />
(81) AL AM AT AU AZ BB BG BR BY CA CH CN<br />
CU CZ DE DK EE ES FI GB GE GH GM GW<br />
HU ID IL IS JP KE KG KP KR KZ LK LR LS LT<br />
LU LV MD MG MK MN MW MX NO NZ PL PT<br />
RO RU SD SE SG SI SK SL TJ TM TR TT UA<br />
UG UZ VN YU ZW; AP (GH GM KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE); OA (BF BJ CF CG<br />
CI CM GA GN ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/46248 (13) A1<br />
(21) PCT/US98/07596<br />
(22) 14 Apr/avr 1998 (14.04.1998)<br />
(25) en (26) en<br />
(31) 60/043,335 (32) 14 Apr/avr 1997 (33) US<br />
(14.04.1997)<br />
(43) 22 Oct/oct 1998 (22.10.1998)<br />
(51) 6 A61K 38/00<br />
(54) • METHOD AND MATERIAL FOR INHIBI-<br />
TING COMPLEMENT<br />
• METHODE ET MATIERE DESTINEES A<br />
L’INHIBITION DU COMPLEMENT<br />
(71, 72) ANDERSON, Byron, E. [US/US]; 5801 Reba,<br />
Morton Grove, IL 60053 (US). FRYER, Jonathan,<br />
P. [US/US]; 474 N. Lake Shore Drive, Chicago, IL<br />
60611 (US).<br />
(74) CROOK, Wannell, M. et al. / etc.; Sheridan Ross<br />
P.C., Suite 3500, 1700 Lincoln Street, Denver, CO<br />
80203–4501 (US).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH GM<br />
GW HU ID IL IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ TM<br />
TR TT UA UG UZ VN YU ZW; AP (GH GM KE<br />
LS MW SD SZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY DE DK<br />
ES FI FR GB GR IE IT LU MC NL PT SE); OA<br />
(BF BJ CF CG CI CM GA GN ML MR NE SN<br />
TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/46249<br />
(21) PCT/US98/07686<br />
(13) A1<br />
(22) 15 Apr/avr 1998 (15.04.1998)<br />
(25) en (26) en<br />
(31) 60/043,023 (32) 15 Apr/avr 1997<br />
(15.04.1997)<br />
(33) US<br />
(43) 22 Oct/oct 1998 (22.10.1998)<br />
(51) 6 A61K 38/00<br />
(54) • METHOD OF TREATING GASTROINTESTI-<br />
NAL ULCERS AND COMPOSITIONS THE-<br />
REFOR<br />
• PROCEDE ET COMPOSITIONS DE TRAI-<br />
TEMENT DES ULCERES GASTRO–<br />
INTESTINAUX<br />
(71) RADIX ORGANIZATION, INC. [US/US];<br />
230 Park Avenue, New York, NY 10169 (US).<br />
CHEMO PATHOLOGY RESOUR CENTER,<br />
INC. [US/US]; 17 Point Sun Drive, Corona del<br />
Mar, Newport Coast, CA 92625 (US).<br />
(72) SZABO, Sandor; 17 Point Sun Drive, Corona del<br />
Mar, Newport Coast, CA 92625 (US).<br />
(74) SEVERSON, Mary, L.; 3295 Dundee Ridge Way,<br />
Duluth, GA 30096 (US).<br />
(81) CA JP; EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE).<br />
Published / Publiée : (c)<br />
(11) WO 98/46250 (13) A1<br />
(21) PCT/US98/07711<br />
(22) 14 Apr/avr 1998 (14.04.1998)<br />
(25) en (26) en<br />
(31) 60/043,545 (32) 14 Apr/avr 1997<br />
(14.04.1997)<br />
(43) 22 Oct/oct 1998 (22.10.1998)<br />
(33) US<br />
(51) 6 A61K 38/08, 38/16, C07K 1/10<br />
(54) • PEPTIDE ANTIESTROGEN COMPOSITIONS<br />
AND METHODS FOR TREATING BREAST<br />
CANCER<br />
• COMPOSITIONS PEPTIDIQUES ANTIOES-<br />
TROGENIQUES ET PROCEDES DE TRAITE-<br />
MENT DU CANCER DU SEIN<br />
(63) US 60/043,545 (CIP)<br />
14 Apr/avr 1997 (14.04.1997)<br />
(71) THE REGENTS OF THE UNIVERSITY OF<br />
CALIFORNIA [US/US]; 22nd floor, 300 Lakeside<br />
Drive, Oakland, CA 94612–3550 (US).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) PIETRAS, Richard, J. [–/US]; 3464 Lisa<br />
Place, Sherman Oaks, CA 91403 (US).<br />
(74) KITCHELL, Barbara, S.; Arnold, White & Durkee,<br />
P.O. Box 4433, Houston, TX 77210 (US).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH GM GW<br />
HU ID IL IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MD MG MK MN MW MX NO NZ<br />
PL PT RO RU SD SE SG SI SK SL TJ TM TR<br />
TT UA UG US UZ VN YU ZW; AP (GH GM KE<br />
LS MW SD SZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY DE DK<br />
ES FI FR GB GR IE IT LU MC NL PT SE); OA<br />
(BF BJ CF CG CI CM GA GN ML MR NE SN<br />
TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/46251 (13) A1<br />
(21) PCT/RU98/00102<br />
(22) 9 Apr/avr 1998 (09.04.1998)<br />
(25) ru (26) ru<br />
(31) 97105213 (32) 11 Apr/avr 1997<br />
(11.04.1997)<br />
(31) 97106270 (32) 11 Apr/avr 1997<br />
(11.04.1997)<br />
(43) 22 Oct/oct 1998 (22.10.1998)<br />
(33) RU<br />
(33) RU<br />
(51) 6 A61K 38/14, A23L 1/30<br />
(54) • IMMUNOMODULATOR AND PHARMA-<br />
CEUTICAL COMPOSITIONS WITH AN-<br />
TITUMOR PROPERTIES, AND A FOOD<br />
ADDITIVE<br />
• REGULATEUR IMMUNOLOGIQUE,<br />
COMPOSITION PHARMACEUTIQUE POS-<br />
SEDANT UNE ACTIVITE ANTITUMORALE<br />
ET ADDITIF ALIMENTAIRE<br />
(71, 72) KALJUZHIN, Oleg Vitalievich [RU/RU];<br />
ul. Zurjupi, 3, NII morfologii cheloveka RAMN,<br />
Moscow, 117418 (RU). SHKALEV, Mikhail<br />
Vladimirovich [RU/RU]; ul. Zurjupi, 3, NII<br />
morfologii cheloveka RAMN, Moscow, 117418<br />
(RU).<br />
(74) MINAEV, Alexei Alexeevich; ul. Krzhizhanovskogo,<br />
20/30–5–115, Tsentr "Junteks",<br />
Moscow, 117218 (RU).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU IL<br />
IS JP KE KG KP KR KZ LC LK LR LS LT LU<br />
LV MD MG MK MN MW MX NO NZ PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TR TT UA UG<br />
US UZ VN YU ZW; AP (GH GM KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE); OA (BF BJ CF CG<br />
CI CM GA GN ML MR NE SN TD TG).<br />
Published / Publiée : (a)<br />
(11) WO 98/46252 (13) A1<br />
(21) PCT/EP98/02112<br />
(22) 9 Apr/avr 1998 (09.04.1998)<br />
(25) de (26) de<br />
(31) 197 15 149.3 (32) 11 Apr/avr 1997 (33) DE<br />
(11.04.1997)<br />
(43) 22 Oct/oct 1998 (22.10.1998)<br />
(51) 6 A61K 38/16, G01N 33/574 // C07K 14/705<br />
(54) • THERAPEUTIC, PROPHYLACTIC AND<br />
DIAGNOSTIC AGENT FOR CANCER, USE-<br />
FUL FOR CHARACTERISING CANCER<br />
CELLS WITH INDIVIDUAL PROPERTIES<br />
• AGENT THERAPEUTIQUE, PROPHYLAC-<br />
TIQUE ET DIAGNOSTIC DU CANCER POUR<br />
CARACTERISER DES CELLULES CANCE-<br />
REUSES A PROPRIETES INDIVIDUELLES<br />
(71) SYMBIOTEC GESELLSCHAFT ZUR FOR-<br />
SCHUNG UND ENTWICKLUNG AUF<br />
DEM GEBIET DER BIOTECHNOLOGIE<br />
MBH [DE/DE]; Auf den Lüppen 8, D–35745<br />
Herborn–Hörbach (DE).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) ZEPPEZAUER, Michael [DE/DE]; Auf den<br />
Hütten 32, D–66133 Scheidt (DE). LEINEN-<br />
BACH, Hans–Peter [DE/DE]; Mauritiusweg 1,<br />
D–66636 Tholey (DE). CLASS, Reiner [DE/US];<br />
53–7 Revere Road, Drexel Hill, PA 19026 (US).<br />
FASSBENDER, Cordula [DE/DE]; Ehrenfeldgürtel<br />
165, D–50823 Köln (DE).<br />
(74) PÄTZOLD, Herbert; Steubstrasse 10, D–82166<br />
Gräfelfing (DE).<br />
(81) AU BG BR CA CN CZ EE GE HU IL JP KR MX<br />
NO NZ PL RU SK TR UA US; EA (AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY DE DK<br />
ES FI FR GB GR IE IT LU MC NL PT SE).<br />
Published / Publiée : (c)<br />
(11) WO 98/46253 (13) A1<br />
(21) PCT/SE98/00682<br />
(22) 14 Apr/avr 1998 (14.04.1998)<br />
(25) en (26) en<br />
(31) 9701409–6 (32) 15 Apr/avr 1997 (33) SE<br />
(15.04.1997)<br />
(43) 22 Oct/oct 1998 (22.10.1998)<br />
(51) 6 A61K 38/17, C07K 14/47<br />
(54) • USE OF CARTILAGE OLIGOMERIC MA-<br />
TRIX PROTEIN FOR THE TREATMENT OF<br />
RHEUMATOID ARTHRITIS<br />
• UTILISATION D’UNE PORINE OLIGO-<br />
MERIQUE DE CARTILAGE POUR LE<br />
TRAITEMENT DE LA POLYARTHRITE<br />
RHUMATOIDE<br />
(71) ASTRA AKTIEBOLAG (publ) [SE/SE]; S–151<br />
85 Södertälje (SE).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) HEINEGÅRD, Dick [SE/SE]; Lunds Universitet,<br />
Dept. of Cell and Molecular Biology,<br />
Sect for Connective Tissue Biology, P.O. Box 94,